Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Shand

Showing results (21-30 of 153) with videos related to

Pageof 16
Sort By:
Clinical Pharmacokinetics|March 1, 1982
Therapeutic drug monitoring of antiarrhythmic agentsJ E Brown, D G Shand
The American Journal of Cardiology|May 22, 1978
Pharmacokinetics of antiarrhythmic drugsR L Woosley, D G Shand
Circulation|August 1, 1978
Propranolol withdrawal syndrome - why?D G Shand, A J Wood
Clinical Pharmacology and Therapeutics|October 1, 1975
Commentary: a physiological approach to hepatic drug clearanceG R Wilkinson, D G Shand
Clinical Pharmacology and Therapeutics|November 1, 1979
Estimation of kinetic parameters from a two-point determination of the drug cumulation factorT D Bjornsson, D G Shand
Pharmacology|January 1, 1972
The disposition of propranolol. I. Elimination during oral absorption in manD G Shand, R E Rangno
Clinical Pharmacology and Therapeutics|September 1, 1973
Hypertensive response to propranolol in a patient treated with methyldopa--a proposed mechansimA S Nies, D G Shand
Circulation|July 1, 1975
Clinical pharmacology of propranololA S Nies, D G Shand
Annals of Internal Medicine|February 1, 1982
Atenolol: a long-acting beta 1- adrenoceptor antagonistA A McLeod, D G Shand
Clinical Pharmacology and Therapeutics|July 1, 1973
Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in manG H Evans, D G Shand
Pageof 16

Showing results (21-30 of 153) with videos related to

Sort By:
Pageof 16
Clinical Pharmacokinetics|March 1, 1982
Therapeutic drug monitoring of antiarrhythmic agentsJ E Brown, D G Shand
The American Journal of Cardiology|May 22, 1978
Pharmacokinetics of antiarrhythmic drugsR L Woosley, D G Shand
Circulation|August 1, 1978
Propranolol withdrawal syndrome - why?D G Shand, A J Wood
Clinical Pharmacology and Therapeutics|October 1, 1975
Commentary: a physiological approach to hepatic drug clearanceG R Wilkinson, D G Shand
Clinical Pharmacology and Therapeutics|November 1, 1979
Estimation of kinetic parameters from a two-point determination of the drug cumulation factorT D Bjornsson, D G Shand
Pharmacology|January 1, 1972
The disposition of propranolol. I. Elimination during oral absorption in manD G Shand, R E Rangno
Clinical Pharmacology and Therapeutics|September 1, 1973
Hypertensive response to propranolol in a patient treated with methyldopa--a proposed mechansimA S Nies, D G Shand
Circulation|July 1, 1975
Clinical pharmacology of propranololA S Nies, D G Shand
Annals of Internal Medicine|February 1, 1982
Atenolol: a long-acting beta 1- adrenoceptor antagonistA A McLeod, D G Shand
Clinical Pharmacology and Therapeutics|July 1, 1973
Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in manG H Evans, D G Shand
Pageof 16